A. Oblin

883 total citations
18 papers, 592 citations indexed

About

A. Oblin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, A. Oblin has authored 18 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in A. Oblin's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (8 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). A. Oblin is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (8 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). A. Oblin collaborates with scholars based in France, United States and Sweden. A. Oblin's co-authors include B. Scatton, Y. Claustre, L. Rouquier, H. Schoemaker, Dominique Fage, Karima Chergui, O. Curet, Jesús Bénavidès, François Gonon and Ghislaine Perrault and has published in prestigious journals such as FEBS Letters, Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A. Oblin

18 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Oblin France 8 260 219 197 97 94 18 592
Hans R. Bürki Japan 11 376 1.4× 162 0.7× 227 1.2× 58 0.6× 55 0.6× 21 605
HS Mayberg United States 5 222 0.9× 113 0.5× 104 0.5× 110 1.1× 93 1.0× 5 506
H.R. Bourne United States 10 214 0.8× 92 0.4× 209 1.1× 42 0.4× 117 1.2× 10 579
Patricia M. Whitaker Canada 10 317 1.2× 127 0.6× 197 1.0× 38 0.4× 59 0.6× 12 484
J.M. Maloteaux Belgium 11 314 1.2× 94 0.4× 225 1.1× 68 0.7× 60 0.6× 21 556
Judit Laszy Hungary 10 275 1.1× 179 0.8× 184 0.9× 74 0.8× 69 0.7× 18 528
P. Granger United States 10 320 1.2× 78 0.4× 201 1.0× 134 1.4× 36 0.4× 17 492
J J Schildkraut United States 13 172 0.7× 112 0.5× 108 0.5× 36 0.4× 107 1.1× 19 687
R. Dorow Germany 14 300 1.2× 82 0.4× 147 0.7× 184 1.9× 70 0.7× 34 647
Andreas E. Theodorou United Kingdom 12 224 0.9× 132 0.6× 124 0.6× 40 0.4× 86 0.9× 14 407

Countries citing papers authored by A. Oblin

Since Specialization
Citations

This map shows the geographic impact of A. Oblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Oblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Oblin more than expected).

Fields of papers citing papers by A. Oblin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Oblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Oblin. The network helps show where A. Oblin may publish in the future.

Co-authorship network of co-authors of A. Oblin

This figure shows the co-authorship network connecting the top 25 collaborators of A. Oblin. A scholar is included among the top collaborators of A. Oblin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Oblin. A. Oblin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Scatton, B., Caroline Cohen, Ghislaine Perrault, et al.. (2001). The preclinical pharmacologic profile of tiapride. European Psychiatry. 16(S1). 29s–34S. 35 indexed citations
2.
Scatton, B., Y. Claustre, Annie Cudennec, et al.. (1997). Amisulpride: from animal pharmacology to therapeutic action. International Clinical Psychopharmacology. 12(Supplement 2). S29–S36. 100 indexed citations
3.
Schoemaker, H., Y. Claustre, Dominique Fage, et al.. (1997). Neurochemical Characteristics of Amisulpride, an Atypical Dopamine D2/D3 Receptor Antagonist with Both Presynaptic and Limbic Selectivity. Journal of Pharmacology and Experimental Therapeutics. 280(1). 83–97. 298 indexed citations
4.
5.
Angel, I., et al.. (1992). Adrenergic and nonadrenergic cotransmitters inhibit insulin secretion during sympathetic stimulation in dogs. American Journal of Physiology-Endocrinology and Metabolism. 263(1). E72–E78. 6 indexed citations
6.
Oblin, A. & B. Živković. (1991). Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists. Fundamental and Clinical Pharmacology. 5(2). 129–138. 2 indexed citations
7.
Angel, I., et al.. (1990). SL 84.0418: a new alpha-2 antagonist with anti-hyperglycaemic properties. European Journal of Pharmacology. 183(3). 990–991. 2 indexed citations
8.
Angel, I., et al.. (1990). Antihyperglycaemic effects of the new alpha-2 antagonist SL 84.0418 in the primate (macaca fascicularis) in comparison with idazoxan. European Journal of Pharmacology. 183(3). 995–996. 7 indexed citations
9.
Curtis‐Prior, P.B., et al.. (1990). Polyphloretin phosphate (PPP) antagonists of prostaglandin action also inhibit prostaglandin biosynthesis in-vitro. Journal of Pharmacy and Pharmacology. 42(9). 660–662. 3 indexed citations
10.
11.
12.
Duverger, D., Lars Edvinsson, Eric T. MacKenzie, et al.. (1987). Concentrations of Putative Neurovascular Transmitters in Major Cerebral Arteries and Small Pial Vessels of Various Species. Journal of Cerebral Blood Flow & Metabolism. 7(4). 497–501. 27 indexed citations
13.
14.
Scatton, B., Dominique Fage, A. Oblin, et al.. (1985). Influence of GABA Mimetics and Lithium on Biochemical Manifestations of Striatal Dopamine Target Cell Hypersensitivity. PubMed. 2. 39–45. 5 indexed citations
15.
Curtis‐Prior, P.B., et al.. (1980). Anti-hypertriglyceridaemic activity of some phenylethylamine anorectic compounds.. PubMed. 4(2). 111–9. 3 indexed citations
16.
Curtis‐Prior, P.B. & A. Oblin. (1979). Variation of pre-incubation times of “prostaglandin synthetase” preparations in relation to subsequent enzyme activity. Prostaglandins and Medicine. 2(4). 319–320. 3 indexed citations
17.
Oblin, A., Jean‐Michel Warnet, Marie‐Claude Jaurand, J Bignon, & Jean‐Roger Claude. (1978). Biological effects of chrysolite after SO2 sorption. iii. effects on the biochemical components of alveolar washing.. PubMed. 59(1). 32–7. 2 indexed citations
18.
Obrénovitch, A, et al.. (1974). Purification of N‐acetyl D‐glucosamine‐binding proteins by affinity chromatography. FEBS Letters. 40(1). 62–66. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans R. Bürki Breakdown of academic impact, for papers by HS Mayberg Breakdown of academic impact, for papers by H.R. Bourne Breakdown of academic impact, for papers by Patricia M. Whitaker Breakdown of academic impact, for papers by J.M. Maloteaux Breakdown of academic impact, for papers by Judit Laszy Breakdown of academic impact, for papers by P. Granger Breakdown of academic impact, for papers by J J Schildkraut Breakdown of academic impact, for papers by R. Dorow Breakdown of academic impact, for papers by Andreas E. Theodorou
Rankless by CCL
2026